Today, numerous law enforcement agencies are casting a wide net and are aggressively pursuing individuals and organizations to detect wrongdoing in the health care arena. Being the target of an investigation can result in severe criminal and civil penalties as well as a loss of reputation. Health care providers and pharmaceutical and medical device manufacturers are operating in an environment of intense scrutiny. In 2011, the Government directed extraordinary resources and attention to detecting and prosecuting health care fraud and abuse, both civilly and criminally; 2012 will continue this trend.
Our panel will address questions such as:
- How have the 2011 cases and settlements shaped enforcement priorities in 2012?
- What is driving the government’s increasing focus on prosecuting individuals and excluding them from federal health care programs?
- How are the Department of Justice and Office of Inspector General identifying fraud and collaborating at both the state and federal levels to target companies and individuals?
- With rewards for whistleblowers at a record high, what are in-house legal and compliance teams doing to proactively handle all potential claims?
Hope S. Foster, Chair, Health Care Enforcement Defense Group
Tracy A. Miner, Chair, White Collar Defense Group
Mintz Levin is an approved CLE provider. This program is accredited in the following states: New York (1.0 credit in the areas of professional practice) and California (1.0 general credit).
Government Health Care Enforcement: How 2011 Actions Are Impacting 2012 Priorities